lysine has been researched along with etoposide in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (13.33) | 18.2507 |
2000's | 4 (26.67) | 29.6817 |
2010's | 8 (53.33) | 24.3611 |
2020's | 1 (6.67) | 2.80 |
Authors | Studies |
---|---|
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
McMahon, J; Nitiss, JL; Vilalta, PM; Wu, H | 1 |
Cole, SP; Falck, J; Jensen, PB; Mirski, SE; Sehested, M; Wessel, I | 1 |
Austin, CA; Lakey, JH; Leontiou, C | 1 |
Kothapalli, N; Sarath, G; Zempleni, J | 1 |
Abbruzzese, A; Agostinelli, E; Budillon, A; Caraglia, M; Giuberti, G; Lombardi, A; Marra, M; Meo, G; Tempera, G | 1 |
Bazan, F; Dixit, VM; Dornan, D; Eastham-Anderson, J; Ferrando, R; French, DM; Huang, DC; Huang, X; Lill, JR; Liu, J; Maecker, H; O'Rourke, K; Schwickart, M; Yue, P | 1 |
Füllgrabe, J; Hajji, N; Hermanson, O; Joseph, B; Vlachos, P; Wallenborg, K | 1 |
Jaiswal, AK; Niture, SK | 1 |
Brooks, CF; Croken, MM; Francia, ME; Gissot, M; Kim, K; Striepen, B | 1 |
Bhattacharjee, S; Espey, MG; Kumar, A; Mason, RP; Sinha, BK | 1 |
Das, S; Kumari, R; Sen, N; Singh, MI | 1 |
Brennum, J; Hamerlik, P; Jensen, KE; Michaelsen, SR; Pedersen, H; Poulsen, HS; Rasmussen, RD; Skjoth-Rasmussen, J; Staberg, M; Villingshøj, M; Vitting-Seerup, K | 1 |
Bao, H; Liu, F; Wang, P; Wang, W; Zhang, XP | 1 |
Arnold, HU; Friesen, TJ; Garrison, SM; Hiatt, JB; Houghton, AM; Liao, SY; MacPherson, D; Martins, R; Norton, JP; Rienhoff, HY; Sandborg, H; Srivastava, S; Sutherland, KD; Wu, F | 1 |
1 review(s) available for lysine and etoposide
Article | Year |
---|---|
Anticancer drugs and hyperthermia enhance cytotoxicity induced by polyamine enzymatic oxidation products.
Topics: Adenosylmethionine Decarboxylase; Amine Oxidase (Copper-Containing); Animals; Antineoplastic Agents; Caspases; Cattle; Cell Proliferation; Docetaxel; Drug Synergism; Etoposide; Eukaryotic Translation Initiation Factor 5A; Humans; Hyperthermia, Induced; Interferon-alpha; Lysine; Ornithine Decarboxylase; Oxidation-Reduction; Peptide Initiation Factors; Polyamines; RNA-Binding Proteins; Taxoids | 2007 |
14 other study(ies) available for lysine and etoposide
Article | Year |
---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Mutations in the gyrB domain of eukaryotic topoisomerase II can lead to partially dominant resistance to etoposide and amsacrine.
Topics: Amino Acid Sequence; Amsacrine; Base Sequence; DNA Gyrase; DNA Topoisomerases, Type II; Drug Resistance; Etoposide; Glycine; Lysine; Molecular Sequence Data; Mutation; Oligodeoxyribonucleotides; Saccharomyces cerevisiae | 1994 |
Loss of amino acids 1490Lys-Ser-Lys1492 in the COOH-terminal region of topoisomerase IIalpha in human small cell lung cancer cells selected for resistance to etoposide results in an extranuclear enzyme localization.
Topics: Amino Acid Sequence; Amino Acid Substitution; Antigens, Neoplasm; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Carcinoma, Small Cell; Cell Nucleus; Consensus Sequence; DNA Topoisomerases, Type II; DNA-Binding Proteins; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Humans; Isoenzymes; Lung Neoplasms; Lysine; Molecular Sequence Data; Molecular Weight; Multidrug Resistance-Associated Proteins; Peptide Fragments; Point Mutation; Polymerase Chain Reaction; RNA, Messenger; Sequence Deletion; Serine; Tumor Cells, Cultured | 1997 |
Mutation E522K in human DNA topoisomerase IIbeta confers resistance to methyl N-(4'-(9-acridinylamino)-phenyl)carbamate hydrochloride and methyl N-(4'-(9-acridinylamino)-3-methoxy-phenyl) methane sulfonamide but hypersensitivity to etoposide.
Topics: Amino Acid Sequence; Amsacrine; Antineoplastic Agents; DNA; DNA Topoisomerases, Type II; Enzyme Stability; Etoposide; Glutamic Acid; Humans; Lysine; Models, Molecular; Mutation; Topoisomerase II Inhibitors; Tranexamic Acid | 2004 |
Biotinylation of K12 in histone H4 decreases in response to DNA double-strand breaks in human JAr choriocarcinoma cells.
Topics: Antineoplastic Agents, Phytogenic; Biotin; Biotinylation; Cell Survival; Choriocarcinoma; DNA; DNA Damage; Etoposide; Histones; Humans; Jurkat Cells; Lysine; Phosphorylation; Pyrimidine Dimers; Serine; Signal Transduction | 2005 |
Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival.
Topics: Animals; Apoptosis; Biphenyl Compounds; Cell Line; Cell Line, Tumor; Cell Survival; DNA Damage; Docetaxel; Etoposide; Female; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Half-Life; Humans; Lysine; Mice; Mice, SCID; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasms; Nitrophenols; Phosphorylation; Piperazines; Polyubiquitin; Prognosis; Protein Binding; Protein Stability; Proto-Oncogene Proteins c-bcl-2; RNA Interference; Sulfonamides; Taxoids; Ubiquitin Thiolesterase; Ubiquitination; Ultraviolet Rays; Xenograft Model Antitumor Assays | 2010 |
Opposing effects of hMOF and SIRT1 on H4K16 acetylation and the sensitivity to the topoisomerase II inhibitor etoposide.
Topics: Acetylation; Animals; Cell Death; Cell Line, Tumor; DNA Damage; Down-Regulation; Drug Resistance, Neoplasm; Enzyme Inhibitors; Etoposide; Histone Acetyltransferases; Histone Deacetylase Inhibitors; Histones; Humans; Hydroxamic Acids; Lysine; Male; Neoplasms; Sirtuin 1; Topoisomerase II Inhibitors; Valproic Acid | 2010 |
INrf2 (Keap1) targets Bcl-2 degradation and controls cellular apoptosis.
Topics: Adaptor Proteins, Signal Transducing; Animals; Antioxidants; Apoptosis; bcl-2-Associated X Protein; Carrier Proteins; Cell Line, Tumor; Cell Survival; Cullin Proteins; Cytoskeletal Proteins; DNA Fragmentation; Etoposide; Gamma Rays; Humans; Hydroquinones; Intracellular Signaling Peptides and Proteins; Kelch-Like ECH-Associated Protein 1; Lung Neoplasms; Lysine; Mice; Phosphorylation; Phosphoserine; Protein Binding; Protein Processing, Post-Translational; Protein Stability; Protein Structure, Tertiary; Proto-Oncogene Proteins c-bcl-2; Ubiquitination; Ultraviolet Rays; Up-Regulation | 2011 |
Toxoplasma gondii sequesters centromeres to a specific nuclear region throughout the cell cycle.
Topics: Cell Cycle; Centromere; Chromatin Immunoprecipitation; Chromosome Breakage; Etoposide; Fluorescent Antibody Technique; Histones; Humans; Lysine; Methylation; Mitosis; Oligonucleotide Array Sequence Analysis; Reproducibility of Results; Toxoplasma | 2011 |
Effect of nitric oxide on the anticancer activity of the topoisomerase-active drugs etoposide and adriamycin in human melanoma cells.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Blotting, Western; Caspase 3; Cell Line, Tumor; Cell Survival; DNA Topoisomerases; Doxorubicin; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; Etoposide; Humans; Lysine; Macrophages; Melanoma; Nitric Oxide; Nitric Oxide Synthase | 2013 |
HDAC5, a key component in temporal regulation of p53-mediated transactivation in response to genotoxic stress.
Topics: Acetylation; Active Transport, Cell Nucleus; Adenoviridae; Animals; Apoptosis; DNA Damage; Etoposide; Gene Expression Regulation; HCT116 Cells; Histone Deacetylases; Humans; Lysine; Mice; Protein Binding; Reactive Oxygen Species; Transcriptional Activation; Tumor Suppressor Protein p53 | 2013 |
Targeting glioma stem-like cell survival and chemoresistance through inhibition of lysine-specific histone demethylase KDM2B.
Topics: Antineoplastic Agents; Apoptosis; Astrocytes; Brain Neoplasms; Cell Line; DNA Damage; Drug Resistance, Neoplasm; Etoposide; F-Box Proteins; Glioblastoma; Histones; Humans; Jumonji Domain-Containing Histone Demethylases; Lomustine; Lysine; Neoplastic Stem Cells; Primary Cell Culture | 2018 |
Regulation of Tip60-dependent p53 acetylation in cell fate decision.
Topics: Acetylation; Apoptosis; Cell Cycle Checkpoints; Cyclin-Dependent Kinase Inhibitor p21; DNA Damage; Etoposide; Gene Expression Regulation; Humans; Lysine; Lysine Acetyltransferase 5; Models, Genetic; PTEN Phosphohydrolase; Signal Transduction; Tumor Suppressor Protein p53 | 2019 |
Inhibition of LSD1 with Bomedemstat Sensitizes Small Cell Lung Cancer to Immune Checkpoint Blockade and T-Cell Killing.
Topics: Animals; Cell Death; Enzyme Inhibitors; Etoposide; Histone Demethylases; Humans; Immune Checkpoint Inhibitors; Lung Neoplasms; Lysine; Mice; Platinum; Small Cell Lung Carcinoma; Tumor Microenvironment | 2022 |